Indrayani Biotech Limited announced unaudited standalone earnings results for third quarter and nine months ended December 31, 2018. For the quarter, the company reported loss before exceptional items and tax of INR 0.218 million against INR 0.124 million a year ago. Net loss was INR 0.218 million against INR 0.124 million a year ago. Basic and diluted loss per share was INR 0.06 against INR 0.03 a year ago. For the nine months, the company reported loss before exceptional items and tax of INR 0.870 million against INR 0.784 million a year ago. Net loss was INR 0.870 million against INR 0.784 million a year ago. Basic and diluted loss per share was INR 0.24 against INR 0.22 a year ago.